Showing results (171-180 of 237) with videos related to

Sort By:
Pageof 24
Cancer Research|November 1, 1993
Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptorD G Kieback, S K McCamant, M F Press, et al.
Gynecologic Oncology|May 29, 2007
Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragmentDonna Badgwell, Zhen Lu, Laurence Cole, et al.
Journal of Medicinal Chemistry|March 30, 2021
Carboxylesterase Notum Is a Druggable Target to Modulate Wnt SignalingElliott D Bayle, Fredrik Svensson, Benjamin N Atkinson, et al.
Cancer Research|July 10, 2007
Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagyShoichiro Ohtani, Arifumi Iwamaru, Wuguo Deng, et al.
Diabetes Research and Clinical Practice|May 23, 2021
Prediabetes and pregnancy: Early pregnancy HbA1c identifies Australian Aboriginal women with high-risk of gestational diabetes mellitus and adverse perinatal outcomesEmma L Jamieson, Erica P Spry, Andrew B Kirke, et al.
Frontiers in Immunology|November 11, 2021
Retinoic Acid Signaling Modulates Recipient Gut Barrier Integrity and Microbiota After Allogeneic Hematopoietic Stem Cell Transplantation in MicePan Pan, Samantha N Atkinson, Brian Taylor, et al.
Cancer|November 15, 1996
Sexual adjustment of patients undergoing gracilis myocutaneous flap vaginal reconstruction in conjunction with pelvic exenterationC R Ratliff, D M Gershenson, M Morris, et al.
Primary Care Diabetes|October 26, 2021
Real-world screening for diabetes in early pregnancy: Improved screening uptake using universal glycated haemoglobinEmma L Jamieson, Erica P Spry, Andrew B Kirke, et al.
Pediatric Neurology|March 23, 2004
Hip status in cerebral palsy after one year of continuous intrathecal baclofen infusionLinda E Krach, Robert L Kriel, Richard C Gilmartin, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 1999
Optically pure (-)-4-[(N-allyl-3-methyl-4-piperidinyl)phenyl-amino]-N,N-diethylbenzami de displays selective binding and full agonist activity for the delta opioid receptorJ B Thomas, R N Atkinson, X M Herault, et al.
Pageof 24